2016 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | 900-1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | 70 |
Total Project Funding: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
Partner Constancy: | 46 |
Project Leadership Index: | 75 |
Diversity Index: | 60 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2010 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2009 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2012 | 0 | 5.999.607 | 545.419 | 1 | ||
2011 | 0 | 4.961.654 | 516.203 | 1 | ||
2010 | 0 | 11.887.735 | 49.998 | 1 |
Total number of partners: 38
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 38
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2012-12-01 | Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) | NET4CGD | participant | 5.999.607 | 11 |
2011-03-01 | Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector | GENEGRAFT | participant | 4.961.654 | 10 |
2010-11-01 | Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency | CELL-PID | participant | 11.887.735 | 20 |